CCR5作为神经认知障碍的关键调节器
Chew Tin Zar Aung1, Khawla Abuaqel1, Miou Zhou1
1College of Dental Medicine, Western University of Health Sciences, Pomona, CA, United States of America.
Experimental neurology
|August 30, 2025
概括
CC化基因受体5型 (CCR5) 是神经炎症和认知功能的关键参与者. 抑制CCR5显示神经认知障碍的治疗潜力,但其复杂的作用需要特定的研究.
科学领域:
- 神经科学
- 免疫学
- 药理学
背景情况:
- 已知CC化基因受体5型 (CCR5) 在免疫反应和艾滋病毒入侵中起作用.
- 新出现的证据强调了CCR5在中枢神经系统功能中的关键作用,包括神经炎症和突触可塑性.
- CCR5涉及到广泛的神经疾病,影响认知功能.
研究的目的:
- 审查CCR5在神经炎症,突触可塑性和认知功能的多方面的作用.
- 探索CCR5在各种神经认知障碍中的参与及其病理机制.
- 讨论针对神经认知障碍的CCR5的治疗潜力和复杂性.
主要方法:
- 对神经疾病中CCR5现有文献的综合性审查.
- 分析CCR5在神经炎症级联和疾病特异性病理中的作用.
- 对基因和药理抑制CCR5的研究的评估.
主要成果:
- 在多种神经疾病中,CCR5在神经元和质细胞上升调节,调节神经炎症和神经元损伤.
- 在临床前模型中,CCR5抑制显示出降低神经炎症,保持大脑功能和提高认知能力的潜力.
- 不同的发现表明CCR5具有复杂的,取决于环境的作用,一些研究表明它具有保护作用.
结论:
- 在中枢神经系统中,CCR5是神经炎症和认知功能的重要调节者.
- 针对CCR5是神经认知障碍的潜在治疗途径,但其复杂的作用需要仔细考虑.
- 未来的研究必须考虑基因背景,细胞特异性影响以及有效的CCR5向干预的特定环境方法.
相关概念视频
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
206
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
206
01:23Role of Neurotransmitters in Memory
964
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
964
01:29Drugs Affecting Neurotransmitter Synthesis
1.6K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.6K
01:26Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
01:22Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.2K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.2K